Exploration of reform paths of high-level talents training in clinical pharmacy

FAN Chenlin; PANG Rui; YAO Wenbing

doi:10.6039/j.issn.1001-0408.2023.06.20

您当前的位置：

首页 >

文章列表页 >

Exploration of reform paths of high-level talents training in clinical pharmacy

更新时间：2023-03-24

- Exploration of reform paths of high-level talents training in clinical pharmacy
- ZHONGGUO YAOFANG Vol. 34, Issue 6, Pages: 746-751(2023)
- 作者机构：
  
  1.中国药科大学发展规划与学科建设处，南京　211198
  2.中国药科大学，南京　211198
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.06.20
  CLC： R95
- Published：30 March 2023，
  
  Received：05 May 2022，
  
  Revised：09 February 2023，
扫描看全文
樊陈琳,庞瑞,姚文兵.临床药学高层次人才培养改革路径探析 ^Δ[J].中国药房,2023,34(06):746-751.

FAN Chenlin,PANG Rui,YAO Wenbing.Exploration of reform paths of high-level talents training in clinical pharmacy[J].ZHONGGUO YAOFANG,2023,34(06):746-751.
樊陈琳,庞瑞,姚文兵.临床药学高层次人才培养改革路径探析 ^Δ[J].中国药房,2023,34(06):746-751. DOI： 10.6039/j.issn.1001-0408.2023.06.20.

FAN Chenlin,PANG Rui,YAO Wenbing.Exploration of reform paths of high-level talents training in clinical pharmacy[J].ZHONGGUO YAOFANG,2023,34(06):746-751. DOI： 10.6039/j.issn.1001-0408.2023.06.20.

摘要

目的

探索临床药学高层次人才培养改革新路径，助力实现我国临床药学教育的高质量发展。

方法

通过专家咨询法就临床药学高层次人才的概念界定和培养的关键环节进行意见征询，结合文献分析法和经验法编制调查问卷，对高校、医院临床药学专业人士进行在线调研。

结果

共反馈有效电子问卷637份。95.13%的受访者认为临床药学高层次人才培养“非常重要”或“比较重要”；51.96%对培养现状表示不同程度的不满；88.85%把“药物临床合理使用”、88.70%把“药物临床研究”作为临床药学高层次人才的主要培养目标定位和服务面向之一；精准药学、循证药学、药物治疗管理、治疗药物监测与评价、新药临床发现与评价等被认为是区别于临床医学高层次人才的重要专业核心知识能力；62.01%认同“学术学位+专业学位双学位”是临床药学高层次人才培养的主要学位类型；79.28%认为“非常必要”或“比较必要”采用长学制教育模式；98.58%认为临床药物治疗学等临床药学专业核心课程“非常重要”或“比较重要”；59.81%认为高校临床药学学院（系）是发挥最主要作用的教育管理组织机构；87.13%认同“高校专任教师+药师”“药师+医师”的双导师组合。

结论

我国应从培养目标定位、核心知识能力、学制学位、课程体系、师资队伍建设等方面入手，加快探索人才培养改革新路径，构建具有中国特色、世界水平的临床药学高层次人才培养体系。

Abstract

OBJECTIVE

To help to realize high-quality development of clinical pharmacy education in China by exploring new reform paths of high-level talents training in clinical pharmacy.

METHODS

The concept definition and key links of high-level talents training in clinical pharmacy were consulted by expert consultation， and the literature analysis and empirical methods were used to prepare a questionnaire to conduct online research on clinical pharmacy professionals in universities and hospitals.

RESULTS

A total of 637 effective electronic questionnaires were received. Totally 95.13% of the respondents believed that the cultivation of high-level talents in clinical pharmacy was very or relatively important； 51.96% expressed different degrees of dissatisfaction with the current situation of training； 88.85% regarded “rational clinical use of drugs” and 88.70% regarded “clinical research of drugs” as one of the main training objectives and service orientation； precision pharmacy， evidence-based pharmacy， medication therapy management， therapeutic drug monitoring and evaluation， clinical discovery and evaluation of new drugs were considered as important core specialty knowledge and competences， which were different from those high-level talents in clinical medicine；62.01% agreed that “academic degree+professional degree” dual degree training was the main degree type for high-level talents training in clinical pharmacy； 79.28% thought it was very necessary or relatively necessary to adopt the “long schooling” education mode； 98.58% thought that the core courses of clinical pharmacy such as clinical pharmacotherapy were very important or relatively important；59.81% believed that college or department of clinical pharmacy was the most important educational management organization that played the most important role； 87.13% agreed with the dual tutor structure of “college teachers+pharmacists” and “pharmacists+physicians”.

CONCLUSIONS

Starting with the target orientation， core knowledge and competence， academic degree system， curriculum system and faculties， it is necessary to speed up the exploration of new reform paths of talent training and build a high-level talent training system of clinical pharmacy with Chinese characteristics and world level.

关键词

临床药学高层次人才培养博士教育改革路径

Keywords

high-level talents trainingdoctor-degree educationreform paths

references

国务院学位委员会第六届学科评议组. 一级学科博士、硕士学位基本要求：下册[M].北京：高等教育出版社，2015:229-238.

国务院办公厅.国务院办公厅关于加快医学教育创新发展的指导意见：国办发〔2020〕34号[EB/OL].（2020-09-17）[2022-04-22]. http：//www.moe.gov.cn/jyb_xxgk/moe_1777/moe_1778/202009/t20200923_490164.htmlhttp://www.moe.gov.cn/jyb_xxgk/moe_1777/moe_1778/202009/t20200923_490164.html.

教育部.教育部介绍《普通高等学校本科专业类教学质量国家标准》有关情况[EB/OL].（2018-01-30）[2022-04-15].http：//www.gov.cn/xinwen/2018-01/30/content_5262-462.htm#1http://www.gov.cn/xinwen/2018-01/30/content_5262-462.htm#1.

姚文兵. 面向临床，加快科学家型药师培养[N]. 健康报，2022-01-26（2）.

周歧骥，廖英勤，黄祖良. 临床药学国内外发展现状及发展建议[J]. 临床合理用药杂志，2022，15（4）：178-181.

陶文慧，李纳，王开元，等. 临床药学专业学位研究生培养模式的现状分析与思考[J]. 沈阳药科大学学报，2021，38（11）：1232-1235.

GRICE G R，GATTAS N M，SAILORS J，et al. Health li-teracy：use of the four habits model to improve student pharmacists’ communication[J]. Patient Educ Couns，2013，90（1）：23-28.

樊陈琳，徐晓媛，于锋，等. 药学教育转型发展与药师型人才培养体系建设的研究与实践[J]. 中华医学教育杂志，2021，41（4）：305-309.

张永泽，张雨菲，张海滨. 我国“博士专业学位”与美国“专业博士”辨析：兼论美国药学博士（Pharm.D.）教育层次[J]. 江苏高教，2020（7）：56-61.

崔一民.医药创新要以临床需求为导向[EB/OL].（2018-03-15）[2022-04-25].http：//health.people.com.cn/n1/2018/0315/c14739-29869190.htmlhttp://health.people.com.cn/n1/2018/0315/c14739-29869190.html.

陈凯先. 生物科技医药创新前沿、我国发展态势和新阶段的若干思考[J]. 中国食品药品监管，2021（8）：4-17.

刘蕙嘉，马国. 人工智能应用于药学服务的探索与思考[J]. 中国临床药学杂志，2020，29（3）：234-238.

胡皓洋，温成铭，刘鑫，等. 基于中文文献分析看我国临床药学研究现状[J]. 中国临床药学杂志，2021，30（2）：107-110.

陈学增，刘嘉欣，刘云娣，等. 药师医师双点评模式在重点监控药品监管中的实践[J]. 中南药学，2022，20（7）：1703-1706.

LIU Z Y，NIE X Y，XIANG Q，et al. Investigations and feedback on the training mode of professional master’s degree of clinical pharmacy in Peking University and the preliminary exploration of Pharm. D. education[J]. JCPS，2018，27（2）：131-137.

复旦大学药学院.研究生教育[EB/OL].[2022-04-05].https：//spfdu.fudan.edu.cn/28412/list.htmhttps://spfdu.fudan.edu.cn/28412/list.htm.

国务院学位委员会，教育部.国务院学位委员会教育部关于印发《研究生教育学科专业目录（2022年）》《研究生教育学科专业目录管理办法》的通知：学位〔2022〕15号[EB/OL].（2022-09-13）[2022-11-05].http：//www.moe.gov.cn/srcsite/A22/moe_833/202209/t20220914_660828.htmlhttp://www.moe.gov.cn/srcsite/A22/moe_833/202209/t20220914_660828.html.

吴凡，汪玲. 构建新时代“MD+PhD”医学教育新模式[J]. 中国卫生资源，2021，24（2）：111-115.

戴婉薇，李佳韵，王晓晓，等. 八年制临床医学毕业医师科研创新能力与困境分析[J]. 医院管理论坛，2022，39（3）：83-86.

聂小燕，唐宁佳，张昕怡，等. 日本国立药学教育新改革调研及其对我国临床药学博士研究生教育的启发与思考[J]. 中国药学杂志，2021，56（22）：1860-1866.

席晓宇，姚东宁，黄元楷，等. 我国三级医院临床药学服务现状及问题研究：二：临床药师团队建设现状分析[J]. 中国药学杂志，2018，53（6）：472-476.

廉立军，孙会清. 知识转移视角下医学创新人才培养三阶段衔接模式构建研究[J]. 中国高等医学教育，2019（2）：7-8.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰